Cancer is the target of most products in advanced clinical development.
Most products in advanced clinical development – that is, Phase III and beyond – target cancer (15 products versus nine products for all other disease categories combined). Two cancer products have been launched (one in the US and one in China); however, the biggest single phase of development category (with 106 products) for cancer is still preclinical trials.
Although the cardiovascular disease category contains far fewer products than the cancer category, two CV products are in Phase III trials (most are in Phase II trials), and one product has been launched (in Russia).
Get your free demo of Datamonitor Healthcare today. Simply fill out the form to the right >>>